Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
03/21/2012 | CN102379885A Pseudo-ginseng triol saponin enteric pellet and capsule and preparation method thereof |
03/21/2012 | CN102379884A Inhibition of fatty acid synthesis by PARP inhibitors and methods of treatment thereof |
03/21/2012 | CN102379877A Western medicinal compound for preventing or treating myocardial ischemic chronic heart failure and application thereof |
03/21/2012 | CN102379876A N-(3- pyridine formex oxygen radical)-3, 5- dimethyl-1- amantadine or pharmaceutically-acceptable salt for treating vascular dementia |
03/21/2012 | CN102379875A Compound preparation containing benidipine hydrochloride and metoprolol tartrate and application thereof |
03/21/2012 | CN102379874A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
03/21/2012 | CN102379871A Use of 5-(4-dimethylaminobenzylidene)-3-(2-ethoxyl)-2-phenylimino-1,3-thiazol-4-one in pharmacy |
03/21/2012 | CN102379869A Oral preparation containing saxagliptin and application thereof |
03/21/2012 | CN102379867A Use of chicoric acid in treatment of fundus lesion |
03/21/2012 | CN102379864A Compound salvianic acid injection for treating cerebral vascular thrombosis diseases and preparation process thereof |
03/21/2012 | CN102379854A Manidipine hydrochloride oral quick release preparation and preparation method thereof |
03/21/2012 | CN102379843A Levocarnitine pharmaceutical composition for injection |
03/21/2012 | CN102379830A Chinese herbal medicine toothpaste |
03/21/2012 | CN102178815B Traditional Chinese medicine for treating ischemic optic neuropathy |
03/21/2012 | CN102085178B Production process for improving stability of enoxaparin sodium injection |
03/21/2012 | CN102028658B Solid preparation containing rosuvastain calcium liposome |
03/21/2012 | CN101972320B Method for extracting ferulic acid, chlorogenic acid and other aicd components from coptis chinensis franch |
03/21/2012 | CN101953865B Chinese medicinal composition for treating ischemic heart diseases and preparation method thereof |
03/21/2012 | CN101919944B Traditional Chinese medicine compound, preparation method and application thereof |
03/21/2012 | CN101919859B Medicinal composition containing pentoxifyllinum and etodolic acid and application thereof |
03/21/2012 | CN101904891B Ginkgo leaf pills and preparation method thereof |
03/21/2012 | CN101884674B Chinese medicament for preventing and treating hypertension |
03/21/2012 | CN101862337B Drug composite containing limaprost and preparation method thereof |
03/21/2012 | CN101810576B Puerarin self-microemulsion composition based on mixed oil and preparation method thereof |
03/21/2012 | CN101732399B Three-herb tea for lowering pressure |
03/21/2012 | CN101721706B Medicine composition containing matrine class alkaloid, preparation method and pharmaceutical application |
03/21/2012 | CN101716271B Chinese traditional medicine effective fraction composite used for curing coronary heart disease and preparation method thereof |
03/21/2012 | CN101708202B Medicament for inhibiting asodilatatioin |
03/21/2012 | CN101628905B C-aryl glucoside sglt2 inhibitors and method |
03/21/2012 | CN101623332B Method for preparing rhizoma corydalis decumbeutis total alkaloids acid salt freeze-drying substance and application of obtained freeze-drying substance |
03/21/2012 | CN101622003B Therapeutic agent for ameliorating prognosis after lower limb amputation surgery |
03/21/2012 | CN101591386B Polypeptide capable of inhibiting excitable and toxic damages and use thereof |
03/21/2012 | CN101591310B Method for preparing cinepazide maleate |
03/21/2012 | CN101559227B Pharmaceutical compositions and their use for manufacturing the medicament for treating atherosclerosis, dyslipidemias and related conditions |
03/21/2012 | CN101549050B Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
03/21/2012 | CN101379048B Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
03/21/2012 | CN101229241B Application of Chinese traditional medicine compounds on preparing medicines promoting mesenchymal stem cells surviving in the body and cardioblast differentiation |
03/21/2012 | CN101199564B Application of sanchi flower total saponine in preparing treatment hypertension disease medicament |
03/21/2012 | CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
03/20/2012 | US8138335 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
03/20/2012 | US8138311 Modified proteins, designer toxins, and methods of making thereof |
03/20/2012 | US8138305 Glucagon-like peptide-1 (glp-1) receptor agonist; diabetes, obesity, glucagonomas, secretory disorders of the airway, metabolic disorder, arthritis, osteoporosis, central nervous system disease, restenosis and neurodegenerative disease. |
03/20/2012 | US8138200 Compositions and methods for double-targeting virus infections and targeting cancer cells |
03/20/2012 | US8138195 Inhibitors of human phosphatidylinositol 3-kinase delta |
03/20/2012 | US8137969 Neural progenitor cells derived from embryonic stem cells |
03/20/2012 | US8137904 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
03/20/2012 | US8137662 Proliferated cell lines and uses thereof |
03/20/2012 | CA2672656C Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
03/20/2012 | CA2553423C Heterocyclic compounds for use in the treatment of cancer and the inhibition of angiogenesis |
03/20/2012 | CA2540196C Pyridine derivatives and use thereof as urotensin ii antagonists |
03/20/2012 | CA2515293C Eicosapentaenoic acid for use in improving prognosis in the treatment of subarachnoid hemorrhage |
03/20/2012 | CA2514507C Methods and compositions for the treatment of gastrointestinal disorders |
03/20/2012 | CA2453510C Treatment of fatigue and cognitive side effects associated with cancer, cancer treatments and menopause with d-threo-methyphenidate |
03/20/2012 | CA2446872C Immune-modulating peptide |
03/20/2012 | CA2405469C Integrin binding peptide derivatives |
03/20/2012 | CA2402719C Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
03/20/2012 | CA2396227C 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
03/20/2012 | CA2392453C Modulation of signal transduction |
03/20/2012 | CA2363067C Compounds and methods to inhibit or augment an inflammatory response |
03/20/2012 | CA2296842C Ligands, including antibodies, showing reactivity against endocrine cells |
03/15/2012 | WO2012033789A2 Treatment of diseases |
03/15/2012 | WO2012033353A2 Sesterterpene compounds and use thereof |
03/15/2012 | WO2012033195A1 Heterocyclic compound |
03/15/2012 | WO2012033149A1 Hetero ring-fused imidazole derivative having ampk activating effect |
03/15/2012 | WO2012032545A1 Processes for preparing dronedarone and its intermediates |
03/15/2012 | WO2012032334A1 Quinoline and quinoxaline derivatives as kinase inhibitors |
03/15/2012 | WO2012031534A1 1,2,3,4,5,6,7,8-octohydro-9-phenylacetamidoacridine, preparation method and pharmaceutical use thereof |
03/15/2012 | WO2012031445A1 Processes for preparing piperazinium salts of kmup and use thereof |
03/15/2012 | WO2012031383A1 Amide compounds |
03/15/2012 | WO2012006516A3 Protein kinase c activators and anticoagulant for the treatment of stroke |
03/15/2012 | WO2012003477A3 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors |
03/15/2012 | WO2011160845A3 Oxidized phospholipids and lipoproteins, and antibodies thereto, as biomarkers of inflammatory conditions and methods of treatment |
03/15/2012 | WO2011146589A8 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles |
03/15/2012 | WO2011103552A3 Amp derivatives for treating cardiac diseases |
03/15/2012 | WO2011018763A8 Combination of proanthocyanidins such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular disorders such as atherosclerosis |
03/15/2012 | US20120066775 Stresscopins and their Uses |
03/15/2012 | US20120065573 Methods of Treating Vascular Lesions |
03/15/2012 | US20120065270 Potassium ion channel modulators and uses thereof |
03/15/2012 | US20120065264 SELF-EMULSIFYING COMPOSITION OF w3 FATTY ACID |
03/15/2012 | US20120065253 Genetic modification of targeted regions of the cardiac conduction system |
03/15/2012 | US20120065237 Methods for treating transthyretin amyloid diseases |
03/15/2012 | US20120065236 Methods for concomitant treatment of theophylline and febuxostat |
03/15/2012 | US20120065231 Thiophene derivative |
03/15/2012 | US20120065227 TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
03/15/2012 | US20120065219 Spirocyclic azaadamantane derivatives and methods of use |
03/15/2012 | US20120065216 Quinazolinedione derivatives as parp inhibitors |
03/15/2012 | US20120065213 C-met protein kinase inhibitors |
03/15/2012 | US20120065212 Heteroarylmethyl amides |
03/15/2012 | US20120065207 Methods for concomitant treatment of theophylline and febuxostat |
03/15/2012 | US20120065202 PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
03/15/2012 | US20120065199 Substituted quinolines for use as vegf inhibitors |
03/15/2012 | US20120065192 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors |
03/15/2012 | US20120065191 Pharmaceutical compounds |
03/15/2012 | US20120065190 Benzazepine compounds as cgrp receptor antagonists |
03/15/2012 | US20120065189 Heterocyclic compounds for the treatment of stress-related conditions |
03/15/2012 | US20120065185 Substituted alkylamine derivatives and methods of use |
03/15/2012 | US20120065181 Method of providing neuroprotection using substituted porphyrins |
03/15/2012 | US20120065180 Androgen pharmaceutical composition and method for treating depression |
03/15/2012 | US20120065171 Fostriecin derivatives and the pharmaceutical uses thereof |
03/15/2012 | US20120065168 Pharmaceutical Hypocholesterolemic Compositions |